MARA Holdings
MARA
Microsoft
MSFT
Coinbase
COIN
Apple
AAPL
Meta Platforms
META
US Stock MarketDetailed Quotes
ANRO Alto Neuroscience
- 3.710
- -0.180-4.63%
Trading Dec 12 10:45 ET
100.06MMarket Cap-1.74P/E (TTM)
3.816High3.695Low75.96KVolume3.810Open3.890Pre Close283.76KTurnover0.39%Turnover RatioLossP/E (Static)26.97MShares24.00052wk High0.61P/B71.94MFloat Cap3.61052wk Low--Dividend TTM19.39MShs Float24.000Historical High--Div YieldTTM3.11%Amplitude3.610Historical Low3.735Avg Price1Lot Size
About Alto Neuroscience Company
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of psychiatric drugs. Its pipeline is composed of five clinical-stage assets which initially target depressive disorder and schizophrenia population. The company was founded by Amit Etkin, Dan Segal, and Wei Wu on March 25, 2019 and is headquartered in Mountain View, CA.
Company Profile
SymbolANRO
Company NameAlto Neuroscience
Listing DateFeb 2, 2024
Issue Price16.00
Founded2019
CEODr. Amit Etkin, M.D.
MarketNYSE
Employees63
Fiscal Year Ends12-31
Address650 Castro Street,Suite 450
CityMountain View
ProvinceCalifornia
CountryUnited States of America
Zip Code94041
Phone1-650-200-0412
Company Executives
- Name
- Position
- Salary
- Dr. Amit Etkin, M.D.
- President, Chief Executive Officer and Chairman of the Board
- 1.86M
- Nicholas Conrad Smith
- Chief Financial Officer and Principal Accounting Officer
- 1.60M
- Adam Savitz
- Chief Medical Officer
- 1.24M
- Michael Conick Hanley, Jr
- Chief Operating Officer
- --
- Andrew Dreyfus
- Independent Director
- 107.37K
- Gwill York
- Independent Director
- 53.68K
- Mahalakshmi Radhakrishnan, M.D.
- Independent Director
- --
- Christopher Nixon Cox
- Independent Director
- --
- Dr. Po Yu Chen
- Independent Director
- --
- Dr. Husseini Manji
- Independent Director
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.